Wilck M, Cornely OA, Cordonnier C, Velez JD, et al. A phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in allogeneic hematopoietic cell transplant recipients (PNEU-STEM). Clin Infect Dis 2023 Jun 20:ciad349. doi: 10.1093.
PMID: 37338158